An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment.

Mater Today Bio

Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.

Published: February 2025

AI Article Synopsis

  • Esophageal cancer ranks as the eighth most common type of cancer globally and is the sixth leading cause of cancer-related deaths.
  • The study introduces an innovative esophageal stent that features a wireless, battery-free, movable photodynamic therapy (PDT) unit, designed for flexible and precise treatment of esophageal tumors.
  • The system integrates a light source for PDT to induce tumor cell death and an electrochemical pneumatic actuator that allows for real-time positioning of the light source, improving targeted therapy based on tumor progression.

Article Abstract

Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related deaths. In this study, we propose a novel esophageal stent equipped with a wireless, battery-free, and movable photodynamic therapy (PDT) unit designed to treat esophageal tumors with flexibility, precision, and real-time control. This system integrates a PDT unit and an electrochemical pneumatic soft actuator into a conventional esophageal stent. Each module incorporates a piezoelectric transducer capable of receiving external ultrasound to power the respective module. These transducers selectively respond to different external ultrasound frequencies, enabling independent operation without mutual interference. The therapy module provides a light source for PDT, inducing the production of cytotoxic reactive oxygen species (ROS) in tumor cells and promoting apoptosis. The pneumatic actuator based on electrochemical principles plays a critical role in controlling the position of the PDT light source, enabling the movement of the therapy module up to 200 mm within 15 min. This allows real-time control to maintain the light source near the tumor, ensuring precise and targeted treatment. The system can wirelessly and in real-time control the PDT light source's position via external ultrasound, offering a novel approach for treating esophageal cancer patients according to the need of tumor's progression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697610PMC
http://dx.doi.org/10.1016/j.mtbio.2024.101394DOI Listing

Publication Analysis

Top Keywords

esophageal stent
12
real-time control
12
external ultrasound
12
light source
12
wireless battery-free
8
battery-free movable
8
esophageal cancer
8
pdt unit
8
therapy module
8
pdt light
8

Similar Publications

An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment.

Mater Today Bio

February 2025

Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China.

Article Synopsis
  • Esophageal cancer ranks as the eighth most common type of cancer globally and is the sixth leading cause of cancer-related deaths.
  • The study introduces an innovative esophageal stent that features a wireless, battery-free, movable photodynamic therapy (PDT) unit, designed for flexible and precise treatment of esophageal tumors.
  • The system integrates a light source for PDT to induce tumor cell death and an electrochemical pneumatic actuator that allows for real-time positioning of the light source, improving targeted therapy based on tumor progression.
View Article and Find Full Text PDF

The management of gastrointestinal anastomotic leaks post surgery is a considerable challenge, characterized by elevated morbidity and mortality, particularly in cases of esophageal-jejunal anastomotic leaks. Diverse endoscopic intervention techniques have been utilized with enhanced success. We present a case where a 57-year-old patient with Siewert type II esophageal cardia cancer underwent endoscopic deployment of a fully covered stent into a fistula resulting from anastomotic leakage, following a laparoscopic proximal gastrectomy with Roux-en-Y and double tract reconstruction.

View Article and Find Full Text PDF

Esophageal cancer is the sixth most common cancer in India with a incidence of around 4.5%. Dysphagia is the primary manifestation of advanced esophageal cancer in 80%-90% of patients.

View Article and Find Full Text PDF

Esophageal stricture is the most common and disabling complication of esophageal injury caused by ingestion of corrosive substances. In our case, the patient developed esophageal stenosis due to ingestion of strong alkaline substances and underwent colon replacement surgery after repeated failed dilation treatments. After surgery, anastomotic stenosis and tracheocolonic fistula occurred successively, and the entire diagnosis and treatment cycle of this disease lasted for more than 20 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!